-
.
it's not clear how well they'll stack up against current migraine therapies, because head-to-head studies haven't been done. .
former novartis exec to lead cambridge diabetes startup semma
. james taylor exclusive: 'i could see my heart stretching my skin. i thought i was going to die'
.james taylor exclusive: 'i could see my heart stretching my skin. i thought i was going to die'
while all of the drugs work on cgrp, they don�t all work the same way. three of them target the cgrp molecule itself. aimovig goes after cgrp's receptor in the brain. . . .
the patient was treated at the royal devon & exeter nhs foundation trust. .
-
.